UBH Denton

ubhdenton.com

University Behavioral Health of Denton is a private freestanding psychiatric hospital specializing in mental health and chemical dependency care. Serving north Texas and surrounding areas since 2005, we provide a wide range of services and programs that offer evidence-based treatment proven to have positive outcomes for our patients. Our inpatient and day hospital, or outpatient, services offer supportive and compassionate care for children, adolescents, adults and mature adults through specialty programs that are tailored to meet the needs of our patients.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

TRANSPARENCY AGGREGATE SPEND & HCP ENGAGEMENT

24th World Congress On Pharmaceutical Research and Drug Discovery

The worlds largest commercial pharma event

Global Pharma And Drug Delivery Summit

Pharma2022

7th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems

Related News

MEDICAL MORPHINE MARKET MAY SEE A BIG MOVE PFIZER, PURDUE PHARMA, HIKMA PHARMACEUTICALS

openPR | April 08, 2020

Advance Market Analytics released the research report of Global Medical Morphine Market, offers a detailed overview of the factors influencing the global business scope. Medical Morphine Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Medical Morphine. This Report covers the emerging player's data, including: competitive situatio...

PHARMA TECH

CSL LIMITED ANNOUNCES TENDER OFFER TO ACQUIRE VIFOR PHARMA LTD

Vifor Pharma Group | December 15, 2021

Global biotechnology leader CSL Limited and Vifor Pharma Ltd, a global specialty pharmaceutical company with leadership in iron deficiency, nephrology & cardio-renal therapies, announced that they have entered into a definitive agreement for CSL to acquire Vifor Pharma for an aggregate equity value for Vifor Pharma of US$ 11.7 / CHF 10.9 billion. CSL has offered to acquire Vifor Pharma in an all-cash tender offer of US$179.25 per share, payable in U.S. dollars.1 The offer assu...

PHARMACY MARKET

NARRATIVA RAISES $1.3M TO HELP PHARMA COMPANIES ACCELERATE THE FDA DRUG APPROVAL PROCESS

Narrativa | May 19, 2021

Narrativa, which has developed an artificial intelligence (AI) medical writing platform to assist pharmaceutical firms in speeding up drug approval and lowering overall compliance costs, recently completed a $1.3 million funding round. The Los Angeles-based firm currently uses its SaaS platform to automate the production of Clinical Study Reports (CSRs) and other regulatory reports for several pharmaceutical firms and other clinical research organizations (CROs). Th...

GRIFOLS TO ACQUIRE MONTREAL-BASED PLASMA FRACTIONATION FACILITY AND TWO PURIFICATION FACILITIES FOR US$460 MILLION

Grifols, Green Cross Corporation | July 21, 2020

Grifols, a global healthcare company and one of world's top producers of plasma-derived medicines, today announced it has executed purchase arrangements with the South Korean-based GC Pharma (Group) whereby Grifols will acquire the Montreal-based plasma fractionation facility and two purification facilities, along with 11 U.S.-based plasma collection centers for a total amount of US$460 million. The transaction is part of Grifols' sustainable global growth strategy to expa...